Europe Organoids Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Organoids Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Organoids Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Organoids Services Market Regional Analysis

6.2 Europe Organoids Services Market Revenue 2021-2031 (US$ Million)

6.3 Europe Organoids Services Market Forecast Analysis

7. Europe Organoids Services Market Analysis – by Type

7.1 Intestine

7.1.1 Overview
7.1.2 Intestine: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Liver

7.2.1 Overview
7.2.2 Liver: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Stomach

7.3.1 Overview
7.3.2 Stomach: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Pancreas

7.4.1 Overview
7.4.2 Pancreas: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Lung

7.5.1 Overview
7.5.2 Lung: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Brain

7.6.1 Overview
7.6.2 Brain: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Kidney

7.7.1 Overview
7.7.2 Kidney: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Others

7.8.1 Overview
7.8.2 Others: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Organoids Services Market Analysis – by Application

8.1 Developmental Biology Disease

8.1.1 Overview
8.1.2 Developmental Biology Disease: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Pathology of Infectious Disease

8.2.1 Overview
8.2.2 Pathology of Infectious Disease: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Regenerative Medicine

8.3.1 Overview
8.3.2 Regenerative Medicine: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Drug Toxicity & Efficacy Testing

8.4.1 Overview
8.4.2 Drug Toxicity & Efficacy Testing: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Drug Discovery & Personalized Medicine

8.5.1 Overview
8.5.2 Drug Discovery & Personalized Medicine: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Others

8.6.1 Overview
8.6.2 Others: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Organoids Services Market Analysis – by Source

9.1 Pluripotent Stem Cells

9.1.1 Overview
9.1.2 Pluripotent Stem Cells: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Organ Specific Adult Stem Cell

9.2.1 Overview
9.2.2 Organ Specific Adult Stem Cell: Europe Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Organoids Services Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Organoids Services Market Breakdown, by Key Country, 2024 and 2031 (%)
10.2.1.1 Europe Organoids Services Market – Revenue and Forecast Analysis – by Country
10.2.1.1 Germany: Europe Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.1.1 Germany: Europe Organoids Services Market Breakdown, by Type
10.2.1.1.2 Germany: Europe Organoids Services Market Breakdown, by Application
10.2.1.1.3 Germany: Europe Organoids Services Market Breakdown, by Source

10.2.1.2 France: Europe Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.2.1 France: Europe Organoids Services Market Breakdown, by Type
10.2.1.2.2 France: Europe Organoids Services Market Breakdown, by Application
10.2.1.2.3 France: Europe Organoids Services Market Breakdown, by Source

10.2.1.3 Italy: Europe Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.3.1 Italy: Europe Organoids Services Market Breakdown, by Type
10.2.1.3.2 Italy: Europe Organoids Services Market Breakdown, by Application
10.2.1.3.3 Italy: Europe Organoids Services Market Breakdown, by Source

10.2.1.4 UK: Europe Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.4.1 UK: Europe Organoids Services Market Breakdown, by Type
10.2.1.4.2 UK: Europe Organoids Services Market Breakdown, by Application
10.2.1.4.3 UK: Europe Organoids Services Market Breakdown, by Source

10.2.1.5 Spain: Europe Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.5.1 Spain: Europe Organoids Services Market Breakdown, by Type
10.2.1.5.2 Spain: Europe Organoids Services Market Breakdown, by Application
10.2.1.5.3 Spain: Europe Organoids Services Market Breakdown, by Source

10.2.1.6 Rest of Europe: Europe Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Organoids Services Market Breakdown, by Type
10.2.1.6.2 Rest of Europe: Europe Organoids Services Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Organoids Services Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 CUSABIO TECHNOLOGY LLC

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Cyprio

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Eurofins Scientific SE

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 HUB Organoids B.V. (Hubrecht Organoid Technology)

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 InnoSer

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 InSphero

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 LABTOO

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Molecular Devices, LLC.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Oncodesign Services

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Sino Biological Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.